298 related articles for article (PubMed ID: 18554755)
41. A role for glycogen synthase kinase-3 in antagonizing mycobacterial immune evasion by negatively regulating IL-10 induction.
Chan MM; Cheung BK; Li JC; Chan LL; Lau AS
J Leukoc Biol; 2009 Aug; 86(2):283-91. PubMed ID: 19401395
[TBL] [Abstract][Full Text] [Related]
42. Novel human in vitro system for evaluating antimycobacterial vaccines.
Kampmann B; Tena GN; Mzazi S; Eley B; Young DB; Levin M
Infect Immun; 2004 Nov; 72(11):6401-7. PubMed ID: 15501770
[TBL] [Abstract][Full Text] [Related]
43. The roles of IL-10 and TGF-beta in controlling IL-4 and IFN-gamma production during experimental Fasciola hepatica infection.
Flynn RJ; Mulcahy G
Int J Parasitol; 2008 Dec; 38(14):1673-80. PubMed ID: 18597757
[TBL] [Abstract][Full Text] [Related]
44. Failure of a Mycobacterium tuberculosis DeltaRD1 DeltapanCD double deletion mutant in a neonatal calf aerosol M. bovis challenge model: comparisons to responses elicited by M. bovis bacille Calmette Guerin.
Waters WR; Palmer MV; Nonnecke BJ; Thacker TC; Scherer CF; Estes DM; Jacobs WR; Glatman-Freedman A; Larsen MH
Vaccine; 2007 Nov; 25(45):7832-40. PubMed ID: 17931755
[TBL] [Abstract][Full Text] [Related]
45. The effect of tuberculin skin test and BCG vaccination on the expansion of PPD-specific IFN-gamma producing cells ex vivo.
Ota MO; Brookes RH; Hill PC; Owiafe PK; Ibanga HB; Donkor S; Awine T; McShane H; Adegbola RA
Vaccine; 2007 Dec; 25(52):8861-7. PubMed ID: 18023944
[TBL] [Abstract][Full Text] [Related]
46. Recombinant DNA vaccine of the early secreted antigen ESAT-6 by Mycobacterium tuberculosis and Flt3 ligand enhanced the cell-mediated immunity in mice.
Xu J; Xu W; Chen X; Zhao D; Wang Y
Vaccine; 2008 Aug; 26(35):4519-25. PubMed ID: 18598729
[TBL] [Abstract][Full Text] [Related]
47. Effect of deworming on human T cell responses to mycobacterial antigens in helminth-exposed individuals before and after bacille Calmette-Guérin (BCG) vaccination.
Elias D; Wolday D; Akuffo H; Petros B; Bronner U; Britton S
Clin Exp Immunol; 2001 Feb; 123(2):219-25. PubMed ID: 11207651
[TBL] [Abstract][Full Text] [Related]
48. Development of a simple, sensitive, rapid test which discriminates BCG-vaccinated from Mycobacterium bovis-infected cattle.
Sopp P; Coad M; Hewinson G; Howard CJ; Cheallaigh CN; Keane J; Harris J; Hope JC
Vaccine; 2008 Oct; 26(43):5470-6. PubMed ID: 18692540
[TBL] [Abstract][Full Text] [Related]
49. The interaction between Helicobacter pylori and atopy: does inverse association really exist?
Cam S; Ertem D; Bahceciler N; Akkoc T; Barlan I; Pehlivanoglu E
Helicobacter; 2009 Feb; 14(1):1-8. PubMed ID: 19191889
[TBL] [Abstract][Full Text] [Related]
50. Primary vaccination and revaccination of young adults with BCG: a study using immunological markers.
Fjällbrant H; Ridell M; Larsson LO
Scand J Infect Dis; 2007; 39(9):792-8. PubMed ID: 17701718
[TBL] [Abstract][Full Text] [Related]
51. Early human infection with Onchocerca volvulus is associated with an enhanced parasite-specific cellular immune response.
Cooper PJ; Mancero T; Espinel M; Sandoval C; Lovato R; Guderian RH; Nutman TB
J Infect Dis; 2001 Jun; 183(11):1662-8. PubMed ID: 11343216
[TBL] [Abstract][Full Text] [Related]
52. Immunogenicity and protective efficacy of a DNA vaccine encoding the fusion protein of mycobacterium heat shock protein 65 (Hsp65) with human interleukin-2 against Mycobacterium tuberculosis in BALB/c mice.
Wang LM; Bai YL; Shi CH; Gao H; Xue Y; Jiang H; Xu ZK
APMIS; 2008 Dec; 116(12):1071-81. PubMed ID: 19133010
[TBL] [Abstract][Full Text] [Related]
53. Cell-mediated immune responses and protective efficacy against infection with Mycobacterium tuberculosis induced by Hsp65 and hIL-2 fusion protein in mice.
Shi C; Yuan S; Zhang H; Zhang T; Wang L; Xu Z
Scand J Immunol; 2009 Feb; 69(2):140-9. PubMed ID: 19144078
[TBL] [Abstract][Full Text] [Related]
54. Interleukin-2 and soluble interleukin-2 receptor levels in children with active pulmonary tuberculosis and atypical mycobacterial adenitis.
Nyabenda J; Turneer M; Waelbroeck A; Duvivier A; Toppet M
Eur Cytokine Netw; 1993; 4(1):43-9. PubMed ID: 8490104
[TBL] [Abstract][Full Text] [Related]
55. Immunological responses and protective immunity in BCG vaccinated badgers following endobronchial infection with Mycobacterium bovis.
Lesellier S; Corner L; Costello E; Lyashchenko K; Greenwald R; Esfandiari J; Singh M; Hewinson RG; Chambers M; Gormley E
Vaccine; 2009 Jan; 27(3):402-9. PubMed ID: 19010372
[TBL] [Abstract][Full Text] [Related]
56. Influence of disease severity on nitrite and cytokine production by peripheral blood mononuclear cells (PBMC) from patients with pulmonary tuberculosis (TB).
Dlugovitzky D; Bay ML; Rateni L; Fiorenza G; Vietti L; Farroni MA; Bottasso OA
Clin Exp Immunol; 2000 Dec; 122(3):343-9. PubMed ID: 11122239
[TBL] [Abstract][Full Text] [Related]
57. Pulmonary delivery of DNA encoding Mycobacterium tuberculosis latency antigen Rv1733c associated to PLGA-PEI nanoparticles enhances T cell responses in a DNA prime/protein boost vaccination regimen in mice.
Bivas-Benita M; Lin MY; Bal SM; van Meijgaarden KE; Franken KL; Friggen AH; Junginger HE; Borchard G; Klein MR; Ottenhoff TH
Vaccine; 2009 Jun; 27(30):4010-7. PubMed ID: 19389445
[TBL] [Abstract][Full Text] [Related]
58. Profile of Th17 cytokines (IL-17, TGF-beta, IL-6) and Th1 cytokine (IFN-gamma) in patients with immune thrombocytopenic purpura.
Ma D; Zhu X; Zhao P; Zhao C; Li X; Zhu Y; Li L; Sun J; Peng J; Ji C; Hou M
Ann Hematol; 2008 Nov; 87(11):899-904. PubMed ID: 18600325
[TBL] [Abstract][Full Text] [Related]
59. Increased IL-4 and decreased regulatory cytokine production following relocation of Icelandic horses from a high to low endoparasite environment.
Hamza E; Torsteinsdottir S; Eydal M; Frey CF; Mirkovitch J; Brcic M; Wagner B; Wilson AD; Jungi TW; Marti E
Vet Immunol Immunopathol; 2010 Jan; 133(1):40-50. PubMed ID: 19640590
[TBL] [Abstract][Full Text] [Related]
60. Inhibition of mycobacterial growth in vitro following primary but not secondary vaccination with Mycobacterium bovis BCG.
Fletcher HA; Tanner R; Wallis RS; Meyer J; Manjaly ZR; Harris S; Satti I; Silver RF; Hoft D; Kampmann B; Walker KB; Dockrell HM; Fruth U; Barker L; Brennan MJ; McShane H
Clin Vaccine Immunol; 2013 Nov; 20(11):1683-9. PubMed ID: 23986316
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
